JORDYN TEMPLE: Open Payments
NPI 1346804812 · WALDRON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 16 payments from 8 companies in 2025. Trend: 2023 $493 · 2024 $0 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| bioMerieux Inc | 1 | $14 |
Products named: FARXIGA, BREZTRI, AIRSUPRA, CAPLYTA, MYFEMBREE, MOUNJARO, REXULTI, NURTEC ODT.
Industry payments across AR — which companies pay providers there.
